TY - JOUR
T1 - Risk-Reducing Gynecological Surgery in Lynch Syndrome
T2 - Results of an International Survey from the Prospective Lynch Syndrome Database
AU - Dominguez-Valentin, Mev
AU - Seppälä, Toni T
AU - Engel, Christoph
AU - Aretz, Stefan
AU - Macrae, Finlay
AU - Winship, Ingrid
AU - Capella, Gabriel
AU - Thomas, Huw
AU - Hovig, Eivind
AU - Nielsen, Maartje
AU - Sijmons, Rolf H
AU - Bertario, Lucio
AU - Bonanni, Bernardo
AU - Tibiletti, Maria Grazia
AU - Cavestro, Giulia Martina
AU - Mints, Miriam
AU - Gluck, Nathan
AU - Katz, Lior
AU - Heinimann, Karl
AU - Vaccaro, Carlos A
AU - Green, Kate
AU - Lalloo, Fiona
AU - Hill, James
AU - Schmiegel, Wolff
AU - Vangala, Deepak
AU - Perne, Claudia
AU - Strauß, Hans-Georg
AU - Tecklenburg, Johanna
AU - Holinski-Feder, Elke
AU - Steinke-Lange, Verena
AU - Mecklin, Jukka-Pekka
AU - Plazzer, John-Paul
AU - Pineda, Marta
AU - Navarro, Matilde
AU - Vidal, Joan Brunet
AU - Kariv, Revital
AU - Rosner, Guy
AU - Piñero, Tamara Alejandra
AU - Gonzalez, María Laura
AU - Kalfayan, Pablo
AU - Sampson, Julian R
AU - Ryan, Neil A J
AU - Evans, D Gareth
AU - Møller, Pål
AU - Crosbie, Emma J
PY - 2020/7/18
Y1 - 2020/7/18
N2 - PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome.METHODS: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT.RESULTS: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and to path_PMS2 carriers in 14/21 (67%). Regarding the involvement of stakeholders, there is global agreement (~90%) that risk-reducing surgery should be offered to women, and that this discussion may involve gynecologists, genetic counselors and/or medical geneticists. Prescription of estrogen-only HRT is offered by 15/21 (71%) centers to women of variable age range (35-55 years).CONCLUSIONS: Most centers offer risk-reducing gynecological surgery to carriers of path_MLH1, path_MSH2 and path_MSH6 variants but less so for path_PMS2 carriers. There is wide variation in how, when and to whom this is offered. The Manchester International Consensus Group developed recommendations to harmonize clinical practice across centers, but there is a clear need for more research.
AB - PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome.METHODS: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT.RESULTS: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and to path_PMS2 carriers in 14/21 (67%). Regarding the involvement of stakeholders, there is global agreement (~90%) that risk-reducing surgery should be offered to women, and that this discussion may involve gynecologists, genetic counselors and/or medical geneticists. Prescription of estrogen-only HRT is offered by 15/21 (71%) centers to women of variable age range (35-55 years).CONCLUSIONS: Most centers offer risk-reducing gynecological surgery to carriers of path_MLH1, path_MSH2 and path_MSH6 variants but less so for path_PMS2 carriers. There is wide variation in how, when and to whom this is offered. The Manchester International Consensus Group developed recommendations to harmonize clinical practice across centers, but there is a clear need for more research.
U2 - 10.3390/jcm9072290
DO - 10.3390/jcm9072290
M3 - Article (Academic Journal)
C2 - 32708519
SN - 2077-0383
VL - 9
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 7
ER -